Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 422
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00068757 | Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | ||
| NCT01724333 | International Validation of the QLQ-OH17 for Oral Health | ||
| NCT00014599 | Paclitaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Vulva | ||
| NCT00003938 | Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients | ||
| NCT06783348 | Radiopharmaceutical Treatment of Advanced Kidney Cancer | ||
| NCT03294746 | Imaging Biomarker in Cancer Drug Induced ILD | ||
| NCT06978062 | Peri-operative Treatment of Resectable Gastroesophageal Cancer Using Bemarituzumab (BEMA) Plus Perioperative Treatment | ||
| NCT00091156 | Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer | ||
| NCT00014300 | Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme | ||
| NCT01597414 | Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1 | ||
| NCT02863055 | Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma | ||
| NCT03005015 | Lenvatinib in Second Line Endometrial Carcinoma | ||
| NCT02307604 | SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access | ||
| NCT00039338 | Chemotherapy Followed By Surgery Vs Radiotherapy Plus Chemotherapy in Patients With Stage IB or II Cervical Cancer | ||
| NCT02205047 | Neoadjuvant Study Using Trastuzumab or Trastuzumab With Pertuzumab in Gastric or Gastroesophageal Junction Adenocarcinoma | ||
| NCT01910376 | Cancer in Nursing Home Residents | ||
| NCT01524926 | CREATE: Cross-tumoral Phase 2 With Crizotinib | ||
| NCT00036868 | Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00030680 | Radiation Therapy in Treating Patients With Aggressive Fibromatoses | ||
| NCT00002777 | Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer | ||
| NCT00005826 | Nitrocamptothecin in Treating Patients With Glioblastoma Multiforme | ||
| NCT00482677 | Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme | ||
| NCT00008034 | Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer | ||
| NCT00027794 | Radical Prostatectomy in Treating Patients With Locally Advanced Prostate Cancer | ||
| NCT03784066 | Durvalumab With or Without Tremelimumab in Resectable Locally Advanced Squamous Cell Carcinoma of the Oral Cavity | ||
| NCT00003805 | Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count | ||
| NCT00263822 | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer | ||
| NCT00027781 | MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT04685616 | Brentuximab Vedotin in Early Stage Hodgkin Lymphoma | ||
| NCT00016211 | Radiation Therapy to Prevent Brain Metastases in Patients With Previously Treated Extensive-Stage Small Cell Lung Cancer | ||
| NCT02214134 | SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access | ||
| NCT03319316 | Combination of Durvalumab and Tremelimumab as Maintenance Treatment in Patients With Non Squamous and Squamous (NSCLC) | ||
| NCT04065165 | Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome | ||
| NCT02172872 | "InDACtion" vs "3+7" Induction in AML | ||
| NCT00003981 | E7070 in Treating Patients With Solid Tumors | ||
| NCT00047112 | Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer | ||
| NCT03437200 | Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer | ||
| NCT00017095 | Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer | ||
| NCT00030511 | Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer | ||
| NCT01164189 | Bevacizumab in Recurrent Grade II and III Glioma | ||
| NCT00110045 | Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant | ||
| NCT03345095 | A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma | ||
| NCT01924819 | Trial of Preoperative Therapy for Gastric and Esophagogastric Junction Adenocarcinoma | ||
| NCT01957436 | A Phase III Study for Patients With Metastatic Hormone-naïve Prostate Cancer | ||
| NCT00006121 | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy | ||
| NCT00006357 | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma | ||
| NCT00003159 | Surgery With or Without Preoperative Chemotherapy in Treating Patients With Resectable Non-small Cell Lung Cancer | ||
| NCT00003062 | Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer | ||
| NCT00002623 | Chemotherapy Followed by Surgery or Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer | ||
| NCT01123473 | Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer |
